International collaborations

The Netherlands Cancer Institute is an active or leading partner in a number of international collaborations.

Cancer Core Europe

Cancer Core Europe (CCE) is an alliance of seven leading European cancer centers that aims to accelerate the development of innovative cancer therapies through close collaboration in translational and clinical research.

Cancer Core Europe (CCE): Accelerating the development of innovative cancer therapies

EACS

The European Academy of Cancer Sciences is an independent advisory body of eminent oncologists and cancer researchers, placing science at the core of policies to sustainably reduce the death and suffering caused by cancer in Europe.

European Academy of Cancer Sciences (EACS): Independent advisory body of eminent oncologists and cancer researchers

EU-LIFE

EU-LIFE is the alliance of independent European research institutes in the life sciences. It aims to improve research by influencing European science policies, and by developing and disseminating best practices in the management of research institutes.

EU-LIFE: Advocating for excellent research in Europe

Euro PDX

The EurOPDX Consortium of translational and clinical researchers focuses on the use and evolution of patient-derived cancer xenograft models. Our group leader Jos Jonkers is on the EurOPDX board.

EURO-PDX:  Sharing PDX models and harmonise characterisation and annotation

Instruct-ERIC

Instruct is a designated European Research Infrastructure Consortium (ERIC) that aims at promoting innovation in biomedical science by making high-end technologies and methods in structural biology available to users.

Instruct-ERIC: Making high-end structural biology tech available

OECI

The Organisation of European Cancer Institutes (OECI) is a non-governmental, non-profit legal Entity established in 1979 to promote greater cooperation among European Cancer Centres and Institutes. Our CFOO Jacqueline Stouthard is on the Board of OECI.

OECI: Promoting cooperation among cancer centers

Precision

Funded by Cancer Research UK and the Dutch Cancer Society, the Precision ‘Grand Challenge’ Team aims at sparing thousands of women unnecessary treatment by finding biomarkers to distinguish between people with DCIS who will develop breast cancer and those who will not.

Precision: Cancer grand team challenges.